Prev Arrow Stocks

UnitedHealth Group Incorporated (DE) ($UNH) Stock Forecast: Down 19.6% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is UnitedHealth Group Incorporated (DE)?

UnitedHealth Group (UNH) is a leading healthcare company providing a wide range of health benefits and services. The company operates through two main platforms: UnitedHealthcare, offering benefits services, and Optum, providing health services. UNH is a key player in the health insurance sector, known for its innovative solutions and strong market presence.

Why is UnitedHealth Group Incorporated (DE) going down?

UNH stock is down 19.6% on Jan 27, 2026 19:05

  • UnitedHealth Group's stock experienced a significant bearish movement of 19% following its Q4 2025 earnings report, where GAAP earnings saw a drastic year-over-year decline.
  • The market reacted negatively to the news of UnitedHealth's plummeting GAAP earnings, which raised concerns about the company's financial performance and outlook.
  • The downward pressure on UNH stock was further intensified by the broader market sentiment towards health insurance companies, as evidenced by the decline in Elevance Health (ELV) stock following UnitedHealth's earnings report.
  • Despite the current sell-off, UnitedHealth Group remains optimistic about a potential rebound in GAAP earnings for 2026, which could present a buying opportunity for investors looking at the long-term growth prospects of the company.

UNH Price Chart

UNH Technical Analysis

UNH News

Liberty Broadband stock hits 52-week low at $42.68

Liberty Broadband Series A (LBRDA) stock has hit a new 52-week low of $42.68, reflecting a significant decline of over 40% in the past year. Despite its low P/E ratio, the company faces short-term liquidity issues as its current ratio is below 1. Investors are closely watching its upcoming earnings report on February 11th, with some analysis suggesting the stock may be undervalued despite recent poor financial performance.

https://www.investing.com/news/company-news/liberty-broadband-stock-hits-52week-low-at-4268-93CH-4468195

0 Missing News Article Image Liberty Broadband stock hits 52-week low at $42.68

Liberty Broadband stock hits 52-week low at $42.77

Liberty Broadband Series C stock has fallen to a new 52-week low of $42.77, marking a significant decline of over 40% in the past year. Despite its "GOOD" financial health and a low P/E ratio of 5.18, the stock continues to face downward pressure. Investors are awaiting the next earnings report on February 11, with analyst targets suggesting potential for undervaluation according to InvestingPro.

https://www.investing.com/news/company-news/liberty-broadband-stock-hits-52week-low-at-4277-93CH-4468192

1 Missing News Article Image Liberty Broadband stock hits 52-week low at $42.77

Why UnitedHealth Group Stock Just Crashed

UnitedHealth Group's stock crashed by 19% after its Q4 2025 earnings report. While adjusted earnings met expectations, GAAP earnings plummeted by nearly 100% year-over-year, from $5.98 to $0.01 per share. Despite the negative Q4 GAAP results, the company forecasts a rebound in GAAP earnings for 2026, potentially making the current sell-off a buying opportunity.

https://www.nasdaq.com/articles/why-unitedhealth-group-stock-just-crashed

2 News Article Image Why UnitedHealth Group Stock Just Crashed

Why Elevance Health (ELV) Stock Is Falling Today

Elevance Health (ELV) stock fell over 11% following news that industry peer UnitedHealth reported a significant drop in quarterly earnings and projected a revenue decline for 2026, raising concerns about rising medical costs across the health insurance sector. A high medical care ratio is expected for Elevance Health, suggesting a larger share of premiums is being spent on claims, squeezing potential profits. This market reaction occurred despite recent positive analyst upgrades for Elevance Health.

https://finviz.com/news/288683/why-elevance-health-elv-stock-is-falling-today

3 News Article Image Why Elevance Health (ELV) Stock Is Falling Today

Earnings call transcript: Northeast Bancorp Q2 2025 results miss revenue forecasts

Northeast Bancorp reported mixed Q2 2025 results, with EPS slightly exceeding forecasts ($2.47 vs. $2.45) but revenue missing significantly ($51.77 million vs. $54.83 million). The stock declined by 5.91% in after-hours trading due to the revenue miss. The company highlighted strong loan and deposit growth, including a new small business loan program, and anticipates higher net interest income in subsequent quarters.

https://www.investing.com/news/transcripts/earnings-call-transcript-northeast-bancorp-q2-2025-results-miss-revenue-forecasts-93CH-4468156

4 Missing News Article Image Earnings call transcript: Northeast Bancorp Q2 2025 results miss revenue forecasts

UnitedHealth Group Incorporated (DE) Price History

29.09.2025 - UNH Stock was down 5.1%

  • UNH saw a decline in its stock despite announcing mixed Q3 results and revising its 2025 EPS forecast upwards. This decrease could be attributed to a significant drop in profits due to escalating medical expenses, causing unease among investors.
  • The company's robust increase in commercial membership and strong performance by Optum Rx were eclipsed by a revenue shortfall and profit decrease, resulting in the downward trend in the market.
  • Well-known hedge fund managers David Tepper and Michael Burry had anticipated a positive quarter from UNH following a notable slump in the previous year. The market's response to the results suggests that their anticipations may not have been wholly fulfilled.
  • Even with UNH predicting a return to sustained growth and raising its 2025 guidance, the company's stock price fell, indicating that investors may have been expecting a more robust performance from UNH.

28.09.2025 - UNH Stock was up 0.8%

  • UNH stock saw a surge following the company's impressive earnings report for the third quarter of 2025. Adjusted earnings surpassed expectations, leading to a positive market response.
  • The company's decision to raise its guidance for 2025 was well-received by investors, signaling a return to sustained growth and boosting confidence in the stock.
  • Investor sentiment was further strengthened by reports of Warren Buffett taking a stake in UNH, contributing to the overall positive outlook for the company.
  • The combination of strong earnings performance and optimistic future prospects were key drivers behind the notable uptick in UNH stock value.

30.09.2025 - UNH Stock was down 4.6%

  • Despite impressive financial performance in revenue and profit growth, UnitedHealth's stock faced downward pressure.
  • Investor concerns about the potential loss of tens of thousands of enrollees in commercial and Medicaid plans may have contributed to the market's negative response.
  • Mixed third-quarter results, characterized by a revenue shortfall but an improved EPS forecast, likely fueled uncertainty among investors and the bearish market trend.
  • The impact of rising medical costs on profits, despite strong growth in commercial membership, may have also influenced the market's reaction.

05.00.2026 - UNH Stock was up 1.0%

  • UnitedHealth Group's strong bullish movement today can be attributed to positive developments in the healthcare and insurance sectors.
  • The increase in price target for Humana, a competitor in the healthcare industry, indicates overall optimism and potential growth in the sector, which could have positively impacted UNH's stock.
  • UnitedHealth Group retaining its lead position in net premiums written showcases its strong market position and stability, likely contributing to investor confidence and buying interest in the stock.
  • Despite a reduction in stake by City Holding Co., the overall institutional investment in the company and its strong financial performance, including surpassing earnings estimates and announcing a dividend, could have outweighed this sell-off, driving the stock price higher.

02.00.2026 - UNH Stock was up 2.6%

  • SteelPeak Wealth LLC increased its stake in UNH, showcasing confidence in the company's future and contributing to positive market sentiment.
  • Although Allspring Global Investments Holdings LLC reduced its holdings in UNH, other institutional investors have displayed interest in the company, reflecting overall market confidence in the stock.
  • UNH is making operational changes post external audits to enhance efficiency and tackle issues impacting profit forecasts, a move that could be positively viewed by investors.
  • Concerns surrounding Medicare Advantage risks and reimbursement pressures affecting Humana's stock may have indirectly favored UNH as investors pursue more stable investment options in the healthcare industry.

27.00.2026 - UNH Stock was down 17.8%

  • UNH stock showed bearish movement, potentially due to profit-taking following a recent uptrend.
  • Positive earnings from Sysco Corp. and the all-time high of CH Robinson Worldwide Inc could have shifted investor focus away from UNH.
  • The mixed performance of Dow Jones and Nasdaq futures, with tech earnings in focus, might have influenced market sentiment, impacting UNH negatively.
  • The appointment of a new Chief Legal Officer at Central Garden & Pet may have generated positive sentiment for the company, diverting attention from UNH.

27.00.2026 - UNH Stock was down 17.7%

  • The bearish movement in UnitedHealth Group (UNH) stock today can be attributed to the following factors:
  • Despite the overall market showing mixed movements, specific healthcare stocks like UnitedHealth Group may have faced pressure due to concerns about potential regulatory changes or shifts in healthcare policies.
  • The underperformance of UnitedHealth Group could also be influenced by company-specific factors such as lower-than-expected earnings, increased competition in the healthcare sector, or changes in reimbursement rates.
  • Investors might be rotating out of healthcare stocks like UnitedHealth Group and into other sectors like technology, as indicated by the positive movements in tech stocks like Cloudflare Inc. and EquipmentShare.com Inc. in pre-market trading.
  • The market may be reacting to news about other companies like Sysco Corp. beating earnings expectations, leading investors to reallocate their investments away from healthcare and into sectors with stronger financial performance.

27.00.2026 - UNH Stock was down 19.2%

  • The stock of UnitedHealth faced significant downward movement today due to lower-than-expected reimbursement rates proposed by the Trump administration for 2027 in the Medicare Advantage sector.
  • UnitedHealth's Q4 report did not meet the expectations of analysts, contributing to the decline in its stock price.
  • Morningstar highlighted the continued regulatory hurdles faced by UnitedHealth in its Medicare Advantage and pharmacy benefit management divisions, adding to market uncertainty.
  • In the broader sector, concerns were exacerbated by Centene's notable stock decrease following the announcement of unanticipated flat payment increases for Medicare Advantage in 2027 by federal regulators.

27.00.2026 - UNH Stock was down 19.5%

  • UnitedHealth's decline in the market is linked to its intention to decrease Medicare Advantage benefits following reduced reimbursement rates proposed for 2027.
  • The stock's drop was also influenced by the negative response to UnitedHealth's earnings report, which did not meet Street expectations.
  • The health insurance sector as a whole, including companies like Elevance Health and CVS Health, is grappling with issues such as stagnant Medicare Advantage rates and regulatory investigations, resulting in a downturn for the sector.
  • Despite UnitedHealth's 2026 profit forecast aligning with projections, ongoing regulatory obstacles in its Medicare Advantage and pharmacy benefit management divisions are causing uncertainty among investors, potentially delaying a significant profit improvement.

27.00.2026 - UNH Stock was down 19.6%

  • UnitedHealth Group's stock experienced a significant bearish movement of 19% following its Q4 2025 earnings report, where GAAP earnings saw a drastic year-over-year decline.
  • The market reacted negatively to the news of UnitedHealth's plummeting GAAP earnings, which raised concerns about the company's financial performance and outlook.
  • The downward pressure on UNH stock was further intensified by the broader market sentiment towards health insurance companies, as evidenced by the decline in Elevance Health (ELV) stock following UnitedHealth's earnings report.
  • Despite the current sell-off, UnitedHealth Group remains optimistic about a potential rebound in GAAP earnings for 2026, which could present a buying opportunity for investors looking at the long-term growth prospects of the company.

18.10.2025 - UNH Stock was down 5.0%

  • The bearish movement in UNH stock could be attributed to the bearish approach adopted by deep-pocketed investors towards the company, as highlighted in the options market analysis.
  • The decrease in short interest as a percent of float may have also contributed to the downward pressure on UNH stock, indicating reduced market optimism towards the company.
  • Despite positive news surrounding other companies in the healthcare sector, the specific bearish sentiment towards UnitedHealth Group seems to have weighed down its stock performance today.

12.10.2025 - UNH Stock was up 5.4%

  • UNH saw a 9.6% decrease in its stock value post Q3 earnings beat, as concerns related to escalating medical expenses and margin pressure tested investor resilience.
  • Options trading on UNH reflected a mix of positive and negative sentiments from affluent investors, contributing to heightened stock volatility.
  • Notably, sizable investors endorsing bullish positions in UNH potentially influenced the robust market upsurge observed.
  • The interplay between conflicting options trends and investor reactions to financial performance likely influenced UNH's market performance.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.